Kyle Mikson
Stock Analyst at Canaccord Genuity
(1.18)
# 3,518
Out of 4,873 analysts
89
Total ratings
32.43%
Success rate
-13.06%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Hold | $87 → $99 | $90.61 | +9.26% | 11 | Jun 11, 2025 | |
| AKYA Akoya Biosciences | Maintains: Hold | $1.8 → $1.08 | $1.29 | -16.28% | 5 | May 19, 2025 | |
| GRAL GRAIL | Maintains: Buy | $32 → $43 | $43.07 | -0.16% | 2 | May 14, 2025 | |
| BDSX Biodesix | Maintains: Buy | $2.5 → $1.5 | $0.27 | +458.24% | 4 | May 14, 2025 | |
| XGN Exagen | Maintains: Buy | $7 → $8 | $6.97 | +14.78% | 3 | May 13, 2025 | |
| QTRX Quanterix | Maintains: Buy | $15 → $12 | $6.30 | +90.48% | 6 | May 13, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $10.79 | +39.02% | 8 | May 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $42 → $37 | $18.87 | +96.08% | 4 | May 6, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $48.55 | +33.88% | 7 | May 1, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $120.11 | +24.89% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.19 | +152.10% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $170.37 | +14.46% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.19 | +152.10% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.5 → $1 | $1.65 | -39.39% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $52.54 | +42.75% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.86 | +132.53% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.61 | +7,924.79% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $3.66 | +419.13% | 1 | Jan 29, 2021 |
Illumina
Jun 11, 2025
Maintains: Hold
Price Target: $87 → $99
Current: $90.61
Upside: +9.26%
Akoya Biosciences
May 19, 2025
Maintains: Hold
Price Target: $1.8 → $1.08
Current: $1.29
Upside: -16.28%
GRAIL
May 14, 2025
Maintains: Buy
Price Target: $32 → $43
Current: $43.07
Upside: -0.16%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.27
Upside: +458.24%
Exagen
May 13, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $6.97
Upside: +14.78%
Quanterix
May 13, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $6.30
Upside: +90.48%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $10.79
Upside: +39.02%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $42 → $37
Current: $18.87
Upside: +96.08%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $48.55
Upside: +33.88%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $120.11
Upside: +24.89%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.19
Upside: +152.10%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $170.37
Upside: +14.46%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.19
Upside: +152.10%
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.65
Upside: -39.39%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $52.54
Upside: +42.75%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.86
Upside: +132.53%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.61
Upside: +7,924.79%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $3.66
Upside: +419.13%